Critical assessment of a proposed model of Shaker
- Published in:
- FEBS Letters, 2004, v. 564, n. 3, p. 257, doi. 10.1016/S0014-5793(04)00273-X
- By:
- Publication type:
- Article
Works by Lainé, Muriel
Results: 6
1
2
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4679, doi. 10.3390/cancers15194679
- By:
- Publication type:
- Article
3
Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.72512
- By:
- Publication type:
- Article
4
Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01843-4
- By:
- Publication type:
- Article
5
Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
6
PARP-1 as a novel target in endocrine-resistant breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03441-4
- By:
- Publication type:
- Article